RNS Number : 3663W
Pharma C Investments PLC
11 December 2023
11 December 2023
Pharma C Investments PLC
("Pharma C" or the "Company")
Results of General Meeting
Pharma C (AQSE: PCIL) held its general meeting ("GM") today at 11:00am. All resolutions set out in the Company's Notice of General Meeting dated 24 November 2023 were proposed and approved.
The Directors of Pharma C take responsibility for this announcement.
For further information please visit www.pharmacinvestments.com
| Pharma C Investments |
|
| Gavin Sathianathan, Investment Strategy Director |
|
| First Sentinel Corporate Finance |
|
| Brian Stockbridge, Corporate Adviser
|
+44 20 3855 5551 |
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
[email protected] or visit
www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.